Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure.
Goldsmith
S R
SR
Hennepin County Medical Center, Cardiology Division, Minneapolis, Minnesota 55415.
Francis
G
G
Cohn
J N
JN
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002216:Captopril / Q000494:pharmacology; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D006333:Heart Failure / Q000097:blood / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D012083:Renin / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D005665:Furosemide; D002216:Captopril; D012083:Renin; D009638:Norepinephrine